Back

Emerging from the darkness: treatment of TTR amyloidosis.

28 August 2021 (10:52 - 11:03)
Organised by:
Congress Presentation Part of: Drug treatment of inherited cardiomyopathies Myocardial Disease ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

4 More presentations in this session

Presentation thumbnail
Targeting the pathophysiology of hypertrophic cardiomyopathy.
Professor I. Olivotto (Florence, IT)
Slides Video
Presentation thumbnail
Imagining a personalised approach to dilated cardiomyopathy.
Professor A. Flammer (Zurich, CH)
Slides Video
Presentation thumbnail
Drug treatment of inherited cardiomyopathies – discussion.
Presentation thumbnail
Drug treatment of inherited cardiomyopathies - Chat Moderator.

Access the full session

Session thumbnail
Drug treatment of inherited cardiomyopathies
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 10:52 CET
You may be interested in
thumbnail
Webinar
New drugs in the treatment of amyloidosis
16 July 2025
thumbnail
Congress Presentation
Symptom burden and clinical characteristics of patients with mutations associated with hereditary transthyretin amyloidosis: insights from referrals by cardiologists to a genetic testing programme
29 June 2021
thumbnail
Congress Presentation
Determinants of circulating transthyretin levels across the clinical spectrum of transthyretin amyloidosis
29 August 2026
thumbnail
Congress Presentation
Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources